Search all medical codes

Helicobacter pylori; drug administration

CPT4 code

Name of the Procedure:

Helicobacter pylori Eradication; Drug Administration (H. pylori Treatment)

Summary

This is a medical procedure involving the administration of a combination of medications to eliminate Helicobacter pylori bacteria from the stomach. H. pylori is a common cause of peptic ulcers and gastritis.

Purpose

The primary purpose of this procedure is to eradicate H. pylori bacteria to treat and prevent peptic ulcers, gastritis, and potential complications such as stomach cancer. The goal is to relieve symptoms, promote healing of the stomach lining, and prevent recurrence.

Indications

  • Persistent stomach pain or discomfort
  • Diagnosis of peptic ulcers or gastritis
  • Positive test for H. pylori infection
  • History of ulcers with confirmed H. pylori presence
  • Symptoms like bloating, nausea, or vomiting associated with H. pylori

Preparation

  • Patients may be advised to avoid eating or drinking for a few hours before the initial dose.
  • Stop certain medications such as proton pump inhibitors (PPIs) or antibiotics before testing and treatment to avoid false results.
  • A prior urea breath test, stool antigen test, or blood test to confirm H. pylori infection.

Procedure Description

  1. Prescription of a combination of antibiotics (typically two) along with a proton pump inhibitor (PPI) and sometimes a bismuth compound.
  2. The patient takes the medications as directed, usually twice daily for 10-14 days.
  3. The regimen might include drugs like clarithromycin, amoxicillin, metronidazole, and tetracycline.
  4. Follow up tests post-treatment to confirm eradication of the bacteria, usually a month after completing the course.

Duration

The treatment typically lasts 10-14 days, with follow-up testing about 4 weeks after the end of the treatment.

Setting

The initial prescription and follow-up are handled in an outpatient setting, such as a doctor's office or clinic.

Personnel

  • Primary care physician or gastroenterologist for diagnosis and prescription
  • Pharmacist for medication dispensation

Risks and Complications

  • Common side effects include nausea, diarrhea, taste distortion, and abdominal pain.
  • Rare but possible risks include antibiotic resistance, allergic reactions, and incomplete eradication of the bacteria.

Benefits

  • Relief from symptoms of ulcers and gastritis within a few days after starting treatment.
  • Healing of the stomach lining and prevention of complications.
  • Reduced risk of recurrence of peptic ulcers.

Recovery

  • Patients are typically able to continue daily activities during treatment.
  • Follow-up visits are essential to confirm eradication.
  • Temporary dietary adjustments might be necessary to manage side effects.

Alternatives

  • Endoscopic treatments for severe cases.
  • H2-receptor blockers as an alternative to PPIs in some cases.
  • Lifestyle modifications, such as avoiding NSAIDs and reducing alcohol intake.
  • Pros and cons include the need for a more invasive approach (endoscopy) or less effective symptom management (lifestyle changes).

Patient Experience

Patients may experience temporary side effects from the medications like taste alterations and mild gastrointestinal upset. Pain relief and symptomatic improvement are common within days of starting treatment. Adherence to medication schedule and follow-up appointments are crucial for successful eradication and recovery.

Similar Codes